Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6138611 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TDP1GAA | |
| SCHEMBL12157045 | 0.79 | ALDH1A1 (0.33) | ALDH1A1TDP1 | |
| SCHEMBL19491568 | 0.79 | ALDH1A1 (0.33) | ALDH1A1TDP1 | |
| SCHEMBL23019027 | 0.78 | TSHR (0.37) | GAA | |
| SCHEMBL15926075 | 0.78 | SMN1; SMN2 (0.35) | ALDH1A1GAA | |
| SCHEMBL23369758 | 0.78 | MMP8 (0.41) | — | |
| Hydrogen Peroxide SCHEMBL5147765 | 0.77 | ALDH1A1 (0.38) | ALDH1A1TDP1GAA | |
| SCHEMBL11615295 | 0.77 | CYP1A2 (0.33) | ALDH1A1TDP1GAA | |
| SCHEMBL19111943 | 0.77 | ALDH1A1 (0.32) | ALDH1A1TDP1GAA | |
| SCHEMBL18930685 | 0.75 | CYP1A2 (0.36) | ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150071872-A1 | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER DRUGS | REXAHN PHARMACEUTICALS INC (US) | 2015-03-12 | — | — | US | disclosed |
| EP-1925630-A1 | THERMOSETTING RESIN COMPOSITION | Nippon Steel Chemical Co., Ltd. (JP) | 2008-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150071872-A1 | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER DRUGS | APEH, LNPEP, CPA3 | ALDH1A1 989/4885TDP1 2359/4885GAA 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.